Back to search

University of Crete (UOC)

The Promyelocytic Leukemia Protein (PML) regulates neural stem cell physiology and confers neuroprotection in a mouse model of Alzheimer’s disease pathology

Abstract

dc:description

The Promyelocytic Leukemia Protein (PML) originally characterized as a tumor suppressor is the core organizer of the subnuclear particles, PML nuclear bodies, which regulate diverse biological properties such as gene transcription, cell cycle, DNA damage responses and apoptosis. In the nervous system, PML was shown to balance proliferation vs differentiation of neural progenitors and have a neuroprotective action during cerebral ischemia. PML has been implicated in the solubility of pathological aggregates in neurodegenerative diseases. However, the molecular and cellular pathways regulated by PML in neuronal cells and its impact on Alzheimer’s disease (AD) neurodegeneration remain unknown. To address this issue, we initially investigated the role of PML in neural stem cell (NSC) fate commitment, stress tolerance and mitochondria metabolism. Employing integrated proteomic and transcriptomic analyses we sought to reveal PML-dependent genes and pathways involved in the regulation of NSC functions and fate commitment. Our findings showed that PML-deficient cells exhibited increased mTOR signaling and protein translation, as well as impaired autophagy and proteasome activity, leading to enhanced formation of aggregates and stress-induced cell death. Furthermore, the ablation of PML disrupted mitochondrial functions, affecting reactive oxygen species, membrane potential, and mitochondrial morphology, processes that are essential for NSC self-renewal, expansion, neurogenesis and tissue homeostasis. We attributed these abnormalities to decreased PGC1α expression and PPARγ activity, that were functionally restored using the PPAR agonist, rosiglitasone. Next, we investigated the role of PML in neuroinflammation and neurodegeneration, employing in vitro and in vivo mouse models for Alzheimer’s disease. To examine the role of PML in neuroinflammation we used intracerebroventricular (ICV) administration of oligomeric amyloid beta 1-42 (oAβ1-42), in WT, Pml-/- mice and primary microglia cultures. To explore the role of PML in AD pathology we employed phenotypic, transcriptomic and behavioral analyses of WT, Pml-/-, 5xFAD and 5xFAD Pml-/- mice. We found that Pml-/- mice displayed reduced recruitment and activation of microglia in the vicinity of οΑβ1-42 injection, accompanied by deregulated expression of disease-associated microglia (DAM) genes. Consistently, Pml-/- primary microglial cultures exhibited reduced phagocytosis, activation, viability and impaired cytokine responsiveness following β-amyloid challenges. PML depletion in 5xFAD mice accelerated Aβ accumulation, impaired microglial activation, lysosomal acidification and recruitment to amyloid plaques while enhanced astrocyte reactivity and neuronal degeneration. Hippocampal transcriptomic analyses revealed in the absence of PML, downregulated pathways related to cell migration, axonogenesis, synapse organization and peroxisomal functions. 5xFAD Pml-/- mice showed suppression of immune response genes and deregulated expression of DAM genes. PML depletion increased hippocampus-dependent behavioral deficits in the context of Aβ pathology, highlighting a role for PML in maintaining cognitive function. Collectively, our findings identify PML as an important regulator for neuronal survival, microglial homeostasis and neuroprotective functions in amyloid pathology.

Degree

thesis:*
Grantor dc:publisher
University of Crete (UOC)
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Spanou, Syragoula
  • Σπανού, Συραγούλα

Subjects

dc:subject × 18

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/61088

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Spanou, Syragoula; Σπανού, Συραγούλα. The Promyelocytic Leukemia Protein (PML) regulates neural stem cell physiology and confers neuroprotection in a mouse model of Alzheimer’s disease pathology. University of Crete (UOC), 2026. http://hdl.handle.net/10442/hedi/61088